Announcement

The demand and need for more plasma has never been higher. Since 2020, the availability of plasma, and where it is located around the world, has increased in relevance as more countries seek to have a measure of self-sufficiency and also control the cost of the most important input into the cost of purified plasma proteins. Most plasma is collected in the United States, but with the rising costs to collect in the current environment, understanding the opportunity for plasma outside of the United States has become even more important.

 This report provides the customer with a global overview of blood collections as well as a comprehensive analysis of all the sources of plasma used for fractionation. This includes, on a worldwide level, plasma recovered from whole blood donations, as well as source plasma, by public/non-profit entities and by private/commercial companies.

 In addition to data on plasma for fractionation, whole blood collections, data on the blood components separated from blood and used for transfusion are included where possible. When it is not used for transfusion, fresh frozen plasma (FFP) can be a source for more plasma for fractionation in some countries, provided that there are no regulatory or legal barriers. The amount of FFP is tracked in this report, when reporting is possible.

 The data is based on an extensive survey conducted by the MRB in over 90 countries in 2023 and 2024. In addition to 2023 full year figures and many 2024 data points, the report provides historical data going back ten years, sometimes longer in key countries.

The following topics are included:

• Organization of Blood Transfusion Services,
• Data on blood & plasma collections, and some recovered and source plasma prices,
• Data on the processing of blood, components and plasma for transfusion.

The table of contents are enclosed below. To inquire about pricing, the full Table of Contents or questions, Contact US